View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 28-2025 FLSmidth & Co. A/S 17 September 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article ...

 PRESS RELEASE

FLS to deliver the world’s largest filtered tailings system to one of ...

FLS to deliver the world’s largest filtered tailings system to one of the largest and most efficient iron ore beneficiation plants PRESS RELEASE FLSmidth & Co. A/S10 September 2025, Copenhagen, Denmark Following a long-standing partnership, a progressive Indian miner and steelmaker has yet again selected FLS to deliver core mining technologies to what is set to become one of the world’s largest, most efficient and sustainable iron ore beneficiation plants globally. This is the fourth consecutive order that FLS has received from the customer within the past nine months. The order includes...

 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 27-2025 FLSmidth & Co. A/S 10 September 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 26-2025 FLSmidth & Co. A/S 3 September 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article ...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

Coloplast A/S - Coloplast lancerer ny 5-årig strategi ’Impact4’

Coloplast A/S - Coloplast lancerer ny 5-årig strategi ’Impact4’ Den nye 5-årige strategi, Impact4, vil blive lanceret i dag på selskabets Capital Markets Day 2025. Strategien Impact4 sætter kunden i centrum og udstikker samtidig et ambitiøst mål for selskabet – at hjælpe 4 millioner mennesker på lang sigt. Med Impact4 fokuserer vi på fire strategiske prioriteter, der er afgørende for vores succes og værdiskabelse: ’Grow through innovative customer offerings’ ved at sætte standarden for sundhedspleje og ved at skabe et stærkt fokus på kunderne på tværs af alle vores forretningsområder.’Unl...

 PRESS RELEASE

Coloplast A/S - Coloplast presents new 5-year strategy, Impact4

Coloplast A/S - Coloplast presents new 5-year strategy, Impact4 The new 5-year strategy, Impact4, will be presented today at the company’s Capital Markets Day 2025 The Impact4 strategy puts customers at the centre of everything we do and sets an ambitious goal for the company – to help 4 million people in the long-term. With Impact4, we focus on four strategic priorities which are essential to our success and value creation: Grow through innovative customer offerings, by setting the standard of care and driving strong customer centricity across all our business areas.Unlock next level e...

 PRESS RELEASE

Coloplast A/S - Announcement no. 07/2025 - Coloplast fremlægger nye fi...

Coloplast A/S - Announcement no. 07/2025 - Coloplast fremlægger nye finansielle forventninger frem mod 2030 I forbindelse med lanceringen af Coloplasts nye 5-årige strategi, Impact4, offentliggør virksomheden en ny finansiel ambition med en organisk omsætningsvækst på 7-8 % (5-årige CAGR) frem til regnskabsåret 2029/30, en vækst i absolut EBIT* på niveau med eller over omsætningsvæksten i perioden og et afkast af investeret kapital (ROIC) på mere end 20 % i regnskabsåret 2029/30. På sin Capital Markets Day den 2. september 2025 vil Coloplast præsentere en ny 5-årig strategi, Impact4. I fo...

 PRESS RELEASE

Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new fin...

Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030   In relation to the launch of Coloplast’s new 5-year strategy, Impact4, the company announces a new financial ambition with organic revenue CAGR of 7-8% until FY 2029/30, growth in absolute EBIT* in line with or above revenue growth over the period and Return on Invested Capital (ROIC) of more than 20% in FY 2029/30. At its Capital Markets Day on 2 September 2025, Coloplast will present a new 5-year strategy, Impact4. In relation to the strategic update, Coloplast is providing a new long-te...

 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 25-2025 FLSmidth & Co. A/S 27 August 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 o...

ABGSC Financials Research ... (+4)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland
  • Simon Brun

Sampo: 1 director

A director at Sampo sold 61,000 shares at 9.973EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Cl...

 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 24-2025  FLSmidth & Co. A/S 20 August 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

FLSmidth & Co. A/S H1 2025 Interim Financial Report: Adjusted EBITA ma...

FLSmidth & Co. A/S H1 2025 Interim Financial Report: Adjusted EBITA margin increased to 15.2% in Q2 2025, driven by the continued execution of our strategic priorities COMPANY ANNOUNCEMENT NO. 23-2025 FLSmidth & Co. A/S 20 August 2025 Copenhagen, Denmark Today, the Board of Directors of FLSmidth have approved the H1 2025 Interim Financial Report. Highlights in Q2 2025: Continued and disciplined execution of our strategic priorities despite macroeconomic and geopolitical uncertaintiesFurther reduction in SG&A driving strong progression in underlying profitability, with an Adjusted EBI...

 PRESS RELEASE

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 S...

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025 Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event.  The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) The event will be held in person at Clarion Hotel in Copenh...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch